Cytokeratin phenotyping does not help in distinguishing oesophageal adenocarcinoma from cancer of the gastric cardia

Journal of Clinical Pathology

Volumn 58, Issue 7, 2005, Pages 722-724

  Van Lier, M G F ^a   Bomhof, F J ^b   Leendertse, I ^b   Flens, M ^b   Balk, A T ^b   Loffeld, R J L F ^a  

^a ZAANS MEDICAL CENTER   (Netherlands)

^b NONE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKERATIN; CYTOKERATIN 20; CYTOKERATIN 7;

ADULT; AGED; ARTICLE; BARRETT ESOPHAGUS; CANCER LOCALIZATION; CARDIA CARCINOMA; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; ESOPHAGUS METASTASIS; EVALUATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; METASTASIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; STOMACH BIOPSY; STOMACH METASTASIS; TECHNIQUE; TISSUE SECTION;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; BARRETT ESOPHAGUS; CARCINOMA, SQUAMOUS CELL; CARDIA; DIAGNOSIS, DIFFERENTIAL; ESOPHAGEAL NEOPLASMS; FEMALE; HUMANS; KERATINS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PRECANCEROUS CONDITIONS; STOMACH NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 21844458739     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2004.024265     Document Type: Article

References (19)

1. Pera M, Cameron AJ, Trasfek VF, et al. Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology 1993;104:510-13.
2. Hansson LE, Sparen P, Nyren O. Increasing incidence of both major histological types of esophageal carcinomas among men in Sweden. Int J Cancer 1993;54:402-7.
3. Blot W, Devesa SS, Fraumeni JF. Continuing climb in rates of esophageal adenocarcinoma: an update. JAMA 1993;270:1320.
4. Prach AT, MacDonal TA, Hopwood DA, et al. Increasing incidence of Barrett's oesophagus: education, enthusiasm, or epidemiology? Lancet 1997;350:933.
5. Cameron AJ. Epidemiology of columnar-lined esophagus and adenocarcinoma. Gastroenterol Clin North Am 1997;26:487-93.
6. Sarbia M, Donner A, Franke C, et al. Distinction between intestinal metaplasia in the cardia and in Barrett's esophagus: the role of histology and immunohistochemistry. Hum Pathol 2004;35:371-6.
7. Shen B, Ormsby AH, Shen C, et al. Cytokeratin expression patterns in noncardia, intestinal metaplasia-associated gastric adenocarcinoma: implication for the evaluation of intestinal metaplasia and tumors at the esophagogastric junction. Cancer 2002;94:820-31.
8. Ormsby AH, Goldblum JR, Rice TW, et al. Cytokeratin subsets can reliably distinguish Barrett's esophagus from intestinal metaplasia of the stomach. Hum Pathol 1999;30:288-94.
9. Taniere P, Borghi-Scoazec G, Saurin JC, et al. Cytokeratin expression in adenocarcinomas of the esophagogastric junction: a comparative study of adenocarcinomas of the distal esophagus and the proximal stomach. Am J Surg Pathol 2002;26:1213-21.
10. Ormsby AH, Goldblum JR, Rice TW, et al. The utility of cytokeratin subsets in distinguishing Barrett's related oesophageal adenocarcinoma from gastric adenocarcinoma. Histopathology 2001;38:307-11.
11. Jovanovic I, Tzardi M, Mouzas IA, et al. Changing pattern of cytokeratin 7 and 20 expression from normal epithelium to intestinal metaplasia of the gastric mucosa and the gastroesophageal junction. Histol Histopathol 2002;17:445-54.
12. Flucke U, Steinborn E, Dries V, et al. Immunoreactivity of cytokeratins (CK7, CK20) and mucin peptide core antigens (MUC1, MUC2, MUC5AC) in adenocarcinomas, normal and metapiastic tissue of the distal oesophagus, oesophago-gastric junction and proximal stomach. Histopathology 2003;43:127-34.
13. DeMeester SR, Wickramasinghe KS, Lord RV, et al. Cytokeratin and DAS-1 immunostaining reveal similarities among cardiac mucosa, CIM, and Barrett's esophagus. Am J Gastroenterol 2002;97:2514-23.
14. Mohammed IA, Streutker CJ, Riddell RH. Utilization of cytokeratins 7 and 20 does not differentiate between Barrett's esophagus and gastric cardiac intestinal metaplasia. Mod Pathol 2002;15:611-16.
15. Gulmann C, Counihan I, Grace A, et al. Cytokeratin 7/20 and mucin expression patterns in oesophageal, cardia and distal gastric adenocarcinomas. Histopathology 2003;43:453-61.
16. Werdmuller B, van der Putten ABMM, Loffeld RJLF. The presentation of gastroesophageal reflux disease: a prospective clinical and endoscopic study. DFS Esophagus 1996;9:285-9.
17. Loffeld RJLF, ABMM van der Putten. The yield of upper gastrointestinal endoscopy: a study of a ten-year period in the "Zaanstreek". Neth J Med 2003;61:18-22.
18. Mandys V, Lukas K, Revoltella R. Different patterns of Cytokeratin expression in Barrett's esophagus-what is beyond? Pathol Res Pract 2003;199:581-7.
19. Kurtkaya-Yapicier O, Gencosmanoglu R, Avsar E, et al. The utility of cytokeratins 7 and 20 (CK7/20) immunohistochemistry in the distinction of snort-segment Barrett esophagus from gastric intestinal metaplasia: is it reliable? BMC Clin Pathol 2003;2:3-5.